Vanguard Group Inc. Sells 43,266 Shares of Humana Inc. $HUM

Vanguard Group Inc. cut its stake in Humana Inc. (NYSE:HUM) by 0.3% in the 3rd quarter, Holdings Channel.com reports. The fund owned 14,155,830 shares of the insurance provider’s stock after selling 43,266 shares during the quarter. Vanguard Group Inc. owned about 0.12% of Humana worth $3,682,922,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Elevation Point Wealth Partners LLC bought a new stake in Humana during the second quarter worth about $32,000. Mather Group LLC. acquired a new position in shares of Humana in the 3rd quarter valued at approximately $34,000. Private Wealth Management Group LLC lifted its holdings in shares of Humana by 47.5% during the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after acquiring an additional 48 shares during the period. AlphaCore Capital LLC acquired a new stake in shares of Humana during the 2nd quarter worth approximately $39,000. Finally, SJS Investment Consulting Inc. increased its stake in Humana by 19,300.0% in the third quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider’s stock valued at $50,000 after acquiring an additional 193 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Stock Up 1.4%

Shares of HUM opened at $187.52 on Thursday. The stock’s 50-day moving average price is $240.52 and its two-hundred day moving average price is $259.61. Humana Inc. has a 12 month low of $169.61 and a 12 month high of $315.35. The company has a market capitalization of $22.55 billion, a PE ratio of 19.10, a PEG ratio of 1.98 and a beta of 0.44. The company has a current ratio of 2.00, a quick ratio of 2.02 and a debt-to-equity ratio of 0.70.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($4.01) by $0.05. Humana had a return on equity of 11.43% and a net margin of 0.92%.The company had revenue of $32.64 billion during the quarter, compared to the consensus estimate of $32.08 billion. During the same period last year, the company earned ($2.16) earnings per share. The firm’s revenue was up 11.3% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. On average, analysts anticipate that Humana Inc. will post 16.47 EPS for the current year.

Analysts Set New Price Targets

HUM has been the subject of several research analyst reports. Leerink Partners lowered their price objective on shares of Humana from $267.00 to $185.00 and set a “market perform” rating for the company in a research report on Thursday, February 12th. The Goldman Sachs Group lowered their price target on Humana from $215.00 to $158.00 and set a “sell” rating for the company in a report on Friday, February 13th. Guggenheim dropped their price objective on Humana from $312.00 to $252.00 and set a “buy” rating for the company in a research report on Thursday, February 12th. Sanford C. Bernstein reiterated an “outperform” rating and issued a $344.00 target price on shares of Humana in a research report on Tuesday, January 6th. Finally, Evercore lowered their target price on Humana from $260.00 to $180.00 in a research note on Thursday, February 12th. Seven investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $228.48.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.